Barclays’s Diebold Nixdorf Incorporated DBD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-3,500
| Closed | -$32K | – | 5778 |
|
|
2021
Q4 | $32K | Hold |
3,500
| – | – | ﹤0.01% | 3904 |
|
|
2021
Q3 | $35K | Hold |
3,500
| – | – | ﹤0.01% | 4217 |
|
|
2021
Q2 | $45K | Hold |
3,500
| – | – | ﹤0.01% | 4185 |
|
|
2021
Q1 | $49K | Sell |
3,500
-153,000
| -98% | -$2.11M | ﹤0.01% | 4208 |
|
|
2020
Q4 | $1.67M | Hold |
156,500
| – | – | ﹤0.01% | 2387 |
|
|
2020
Q3 | $1.2M | Sell |
156,500
-11,100
| -7% | -$81.6K | ﹤0.01% | 2528 |
|
|
2020
Q2 | $1.02M | Sell |
167,600
-1,600
| -0.9% | -$7.89K | ﹤0.01% | 2741 |
|
|
2020
Q1 | $596K | Sell |
169,200
-64,900
| -28% | -$550K | ﹤0.01% | 3443 |
|
|
2019
Q4 | $2.47M | Hold |
234,100
| – | – | ﹤0.01% | 2774 |
|
|
2019
Q3 | $2.62M | Buy |
234,100
+230,300
| +6,061% | +$2.73M | ﹤0.01% | 2532 |
|
|
2019
Q2 | $35K | Sell |
3,800
-500
| -12% | -$5.22K | ﹤0.01% | 6241 |
|
|
2019
Q1 | $48K | Buy |
+4,300
| New | +$30.1K | ﹤0.01% | 5913 |
|
|
2018
Q4 | – | Sell |
-4,100
| Closed | -$18K | – | 7482 |
|
|
2018
Q3 | $18K | Sell |
4,100
-10,500
| -72% | -$76.6K | ﹤0.01% | 6500 |
|
|
2018
Q2 | $174K | Sell |
14,600
-1,800
| -11% | -$24.1K | ﹤0.01% | 4838 |
|
|
2018
Q1 | $253K | Buy |
16,400
+8,300
| +102% | +$139K | ﹤0.01% | 4629 |
|
|
2017
Q4 | $132K | Sell |
8,100
-13,200
| -62% | -$255K | ﹤0.01% | 5026 |
|
|
2017
Q3 | $487K | Buy |
21,300
+16,300
| +326% | +$347K | ﹤0.01% | 3654 |
|
|
2017
Q2 | $140K | Buy |
5,000
+1,400
| +39% | +$38.7K | ﹤0.01% | 4666 |
|
|
2017
Q1 | $111K | Buy |
3,600
+100
| +3% | +$2.82K | ﹤0.01% | 4806 |
|
|
2016
Q4 | $88K | Buy |
3,500
+1,700
| +94% | +$40.1K | ﹤0.01% | 4838 |
|
|
2016
Q3 | $45K | Buy |
1,800
+1,600
| +800% | +$42.5K | ﹤0.01% | 5037 |
|
|
2016
Q2 | $5K | Sell |
200
-500
| -71% | -$12.9K | ﹤0.01% | 5752 |
|
|
2016
Q1 | $20K | Hold |
700
| – | – | ﹤0.01% | 5220 |
|
|
2015
Q4 | $21K | Buy |
700
+600
| +600% | +$20.4K | ﹤0.01% | 5176 |
|
|
2015
Q3 | $3K | Sell |
100
-2,000
| -95% | -$65K | ﹤0.01% | 6255 |
|
|
2015
Q2 | $74K | Buy |
2,100
+700
| +50% | +$24.7K | ﹤0.01% | 4893 |
|
|
2015
Q1 | $49K | Hold |
1,400
| – | – | ﹤0.01% | 5291 |
|
|
2014
Q4 | $48K | Sell |
1,400
-23,800
| -94% | -$839K | ﹤0.01% | 5760 |
|
|
2014
Q3 | $882K | Buy |
25,200
+22,900
| +996% | +$864K | ﹤0.01% | 3470 |
|
|
2014
Q2 | $92K | Buy |
+2,300
| New | +$88.2K | ﹤0.01% | 5482 |
|
|
2014
Q1 | – | Sell |
-17,100
| Closed | -$564K | – | 7758 |
|
|
2013
Q4 | $564K | Sell |
17,100
-10,400
| -38% | -$324K | ﹤0.01% | 3976 |
|
|
2013
Q3 | $798K | Sell |
27,500
-7,400
| -21% | -$232K | ﹤0.01% | 3599 |
|
|
2013
Q2 | $1.18M | Buy |
+34,900
| New | +$1.08M | ﹤0.01% | 3156 |
|
Barclays's DBD Position: Q3 2023 in Review
Barclays sold out of Diebold Nixdorf Incorporated (DBD) in Q3 2023, closing a stake of 25,865 shares — an estimated $1.37K sold.
Barclays first reported a position in DBD in Q2 2013 and held it in 41 quarters. The position peaked at $4.89M in Q3 2019. 0 funds tracked by Wall St. Rank hold DBD as of Q3 2023.
- Barclays reported no remaining Diebold Nixdorf Incorporated position as of Q3 2023 after selling out during the quarter.
- Barclays sold 25,865 Diebold Nixdorf Incorporated shares in Q3 2023, an estimated $1.37K.
- Barclays first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 41 quarters.
- Barclays's Diebold Nixdorf Incorporated position peaked at $4.89M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q3 2023.
Based on Barclays's 13F filing for Q3 2023, filed 7 Nov 2023.